News

Earnings Forecast and Performance Insights for Interface

Earnings Forecast and Performance Insights for Interface

Understanding Interface's Upcoming Earnings Report

Interface (NASDAQ: TILE) is on the brink of releasing its quarterly earnings report, creating a buzz among investors as they look for insights into the company's current performance. As the date approaches, expectations are building around the anticipated figures and the guidance that will follow.

Anticipated Earnings and Market Reactions

Analysts are predicting an earnings per share (EPS) of $0.47 for Interface. This figure becomes even more significant as investors are not only concerned with the actual earnings but also with the guidance that follows. Market movements often derive more from future expectations than past results, making the guidance a focal point.

Reviewing Previous Earnings Performance

In the last earnings report, Interface exceeded expectations by reporting an EPS that was $0.13 higher than forecasts, although this resulted in a slight drop in share price of 0.0% the next day. This highlights an interesting dynamic in the marketplace where sometimes, strong earnings aren't enough to bolster stock prices if the guidance does not align with investor expectations.

A Glance at Quarterly Performance

Here’s a snapshot of Interface’s recent financial performance:

Quarter Q2 2025 Q1 2025 Q4 2024 Q3 2024
EPS Estimate 0.47 0.21 0.29 0.34
EPS Actual 0.60 0.25 0.34 0.48
Price Change % 19.00 2.00 5.00 33.00

Current Stock Market Dynamics

As of the last trading day on October 29, shares of Interface were valued at $26.57, a significant appreciation of 15.12% over the past year. For long-term investors looking ahead to the upcoming earnings call, these figures suggest a solid performance, aligning with a generally optimistic investor sentiment.

Market Sentiment and Analyst Ratings

In terms of market sentiment, analysts remain positive about Interface’s prospects. The consensus rating is currently set at Outperform, based on three analyst ratings, with an average price target of $32.0. This presents a potential upside of 20.44%, indicating that analysts believe the stock may have room for growth in the near term.

Comparative Analysis with Peers

Understanding the broader context, let us look at how Interface compares with industry peers, particularly ACCO Brands, in terms of growth and performance metrics. Here's a brief overview:

Company Consensus Revenue Growth Gross Profit Return on Equity
Interface Outperform 8.33% $147.98M 5.99%
ACCO Brands Outperform -9.92% $129.70M 4.70%

Interface demonstrates superior performance in revenue growth and gross profit when compared to its peers, although it trails in terms of ROE compared to the industry average.

Company Overview and Financial Health

Interface Inc specializes in the design, manufacturing, and supply of carpet tiles, including Luxury Vinyl and rubber flooring, primarily serving corporate and commercial sectors such as government, healthcare, and education markets. The company is split into two significant revenue-generating segments: Americas and Europe, Africa, Asia and Australia.

Financial Metrics

Market Capitalization: Interface boasts a market capitalization that puts it above many competitors, reflecting its substantial size and influence in the industry.

Revenue Growth: The company has reported an impressive revenue growth of approximately 8.33%, indicating robust sales and good demand for its products.

Net Margin: With a remarkable net margin of 8.67%, Interface showcases its ability to maintain profitability against industry benchmarks.

Return on Equity (ROE): The company's ROE is 5.99%, which, while lower than some peers, still demonstrates effective management of shareholders’ equity.

Return on Assets (ROA): Interface shows a strong ROA at 2.64%, indicating efficiency in utilizing its assets for generating earnings.

Debt Management: The debt-to-equity ratio is noteworthy at 0.68, suggesting a higher reliance on debt financing but also raises questions regarding financial risk.

Frequently Asked Questions

When will Interface report their earnings?

Interface is scheduled to release its quarterly earnings results shortly, which is highly anticipated by investors.

What is the expected EPS for this quarter?

The expected EPS for Interface for the upcoming quarter is projected to be $0.47.

How has Interface performed in the past quarter?

Last quarter, Interface reported an EPS of $0.60, surpassing estimates by $0.13.

What is the consensus rating for Interface?

Currently, the consensus rating for Interface stands at Outperform, indicating positive sentiment among analysts.

What sets Interface apart from its peers?

Interface leads in revenue growth and gross profits compared to its peers, although it has some room to improve on return on equity.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

4Roots Picks MSG for IT & Cybersecurity Support

Updated Category News Views 0

Tech-Boost for a Community Farm Vision Seems like everyone's buzzing about sustainability these days, and why not? It's the way forward. Take 4Roots and their Farm Campus initiative in Orlando. They've hooked up with Managed Services Group (MSG) to bolster their tech backbone, raising the stakes for their mission to shake up the food system. It's a no-nonsense...

Continue Reading
Better's 90-Day Plan: Growth Amidst Governance Gamble

Updated Category News Views 0

Unpacking the Ambitious 90-Day Plan When you hear Vishal Garg's name next to a 90-day sprint plan, it's not your everyday boardroom shuffle—you know there's grit behind the screen. Better Home & Finance (BETR) is angling for a massive turnaround with its latest rollout, but whether it's all sizzle and no steak is what we're here to figure out. Financial Metrics and...

Continue Reading
Photronics Investors Must Act by Sept. 4, 2026 Deadline

Updated Category News Views 0

Action Time for Photronics Investors There's nothing like a looming deadline to get the adrenaline pumping, especially when you're staring down the barrel of a federal securities class action. Photronics, Inc. (NASDAQ: PLAB) has found itself tangled in legal webs, with the clock ticking down to September 4, 2026. That’s the deadline for investors to move on being the...

Continue Reading
TELUS Digital Shakes Up Dreamforce with Exclusive Session

Updated Category News Views 17

What's Cooking at Hotel Zetta? Ever see a company shake up an event like TELUS Digital is about to at Dreamforce 2026? Instead of the usual booth schmooze-fest at Moscone Center, these folks are camping at Hotel Zetta with a packed 'boutique' agenda. From September 15–16, they're rolling out serious insider sessions for the big brains in financial services, education,...

Continue Reading
Wise Group Investors Alert Ahead of Key Legal Deadline

Updated Category News Views 0

Sizing Up the Legal Stakes for Wise Group Alright, here's a doozy that's bound to get your attention if you've got a stake in Wise Group plc (NASDAQ: WSE). We're talking about a looming securities class action, with the deadline to get involved barreling down like a runaway freight train. Before September 29, 2026, to be exact—mark it, circle it, do whatever you have to...

Continue Reading
PLAY Palm Angels Launches at Pacsun with Avani Gregg

Updated Category News Views 3

Revamping Streetwear with PLAY Palm Angels and Pacsun In a move that's making waves from the fashion runways straight into the heart of youth culture, PLAY Palm Angels is swooping into Pacsun, and they’re not just strolling in—they’re parading with a 41-piece fashion collection. Not to mention, they've snagged Avani Gregg, a powerhouse cultural influencer, to strut...

Continue Reading
Tahoe Truckee Life TV Series Elevates Local Flavor

Updated Category News Views 2

Meet “Tahoe Truckee Life” Kane Schaller, the face of the Tahoe Truckee Life series, is giving folks a front-row seat to the lives and landscapes that make the Reno-Tahoe region buzz. Now, I've seen shows trying to pull this off, but this one might just spark something genuine if done right. The Real Deal on Reno-Tahoe The show airs on the REAL Shows Network—a...

Continue Reading
Catholic Colleges Excel in AI Readiness, Study Shows

Updated Category News Views 3

Faith and Tech: An Unexpected Alliance? Alright, here's something that'll make you sit up: Catholic college grads are not just busy sipping their morning coffee while they muse over moral philosophy—they're out there on the front lines of artificial intelligence, better prepared and more engaged than their peers from secular schools. According to the latest Holistic...

Continue Reading
Médunik Canada Boosts Dravet Syndrome Support with Biocodex

Updated Category News Views 1

Breaking Down the Exclusive Médunik-Biocodex Partnership Listen, when a company like Médunik Canada, firmly rooted in Blainville, QC, throws its weight behind a rare disease drug like Diacomit®, folks in the industry take notice. Their recent handshake with Biocodex isn't just small talk; it opens doors to change how Dravet syndrome is managed across Canada. This new...

Continue Reading
EzCheckPrinting Boosts Remote Check Solutions Cost-Effectively

Updated Category News Views 1

Navigating the Check Printing Landscape Let's dive right into the changing realities of the workspace. With remote work becoming the new standard, small businesses are juggling tighter budgets while trying to maintain smooth financial operations. It's a hard game, but here is where Halfpricesoft.com rolls out their newly upgraded multi-user ezCheckPrinting software,...

Continue Reading

Top 5 Most Recently Viewed Articles

Uncovering Legal Options for MoonLake Immunotherapeutics Investors

Updated Category News Views 185

Overview of MoonLake Immunotherapeutics Class Action Investors in MoonLake Immunotherapeutics (NASDAQ: MLTX) have recently found themselves facing significant challenges. The disclosures regarding the company’s operations and the marketing of its products have prompted questions about the integrity of the information provided to shareholders. Why a Class Action? In a...

Continue Reading
BioCryst Sells European ORLADEYO Business for $250 Million

Updated Category News Views 184

BioCryst Concludes Successful Sale of European ORLADEYO Business In a significant move, BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) has confirmed the successful sale of its European ORLADEYO business to Neopharmed Gentili. This transaction is valued at $250 million and includes the potential for up to $14 million in future milestones linked to sales across Central and...

Continue Reading
Investors of Edwards Lifesciences Urged to Seek Legal Counsel

Updated Category News Views 200

Overview of Investor Rights in the Edwards Lifesciences Case In today's financial landscape, safeguarding your investments is paramount. Edwards Lifesciences Corporation (NYSE: EW) has emerged as a notable player in the healthcare sector, particularly in innovative heart valve therapies. However, recent events have raised concerns among shareholders, prompting calls for...

Continue Reading
Accuray Unveils Innovative Radiotherapy Solution for Cancer Care

Updated Category News Views 174

Revolutionizing Radiotherapy with Accuray Stellar Accuray, a leader in adaptive radiotherapy, has launched the Accuray Stellar™ Solution, which is designed to transform cancer care. This innovative solution offers an expansive toolbox that empowers clinical teams to adapt treatments to fit each patient's unique needs. Accuray's commitment to enhancing radiotherapy...

Continue Reading
Scale Computing Shines on Prestigious AI 100 Awards List

Updated Category News Views 191

Scale Computing Shines on Prestigious AI 100 Awards List Scale Computing, the market leader in edge computing and hyperconverged solutions, has recently made waves in the tech industry by being recognized on the annual CRN AI 100 list. This list marks a milestone as it celebrates companies that are at the forefront of innovation in artificial intelligence. Understanding...

Continue Reading